{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:44:55Z","timestamp":1790783095310,"version":"4.1.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2012,5,30]],"date-time":"2012-05-30T00:00:00Z","timestamp":1338336000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0038111","type":"journal-article","created":{"date-parts":[[2012,5,30]],"date-time":"2012-05-30T21:38:27Z","timestamp":1338413907000},"page":"e38111","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":48,"title":["An In Situ Autologous Tumor Vaccination with Combined Radiation Therapy and TLR9 Agonist Therapy"],"prefix":"10.1371","volume":"7","author":[{"given":"Huagang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laibin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekambar R.","family":"Kandimalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Bin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandan","family":"Guha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,5,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1056\/NEJM199502093320607","article-title":"Recent advances in radiation oncology.","volume":"332","author":"AS Lichter","year":"1995","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijrobp.2005.08.036","article-title":"Radiation-enhanced immune response to cancer: workshop, Anaheim, CA, April 17, 2005.","volume":"64","author":"RM Sutherland","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.2174\/1381612023394089","article-title":"Immune modulation by ionizing radiation and its implications for cancer immunotherapy.","volume":"8","author":"EJ Friedman","year":"2002","journal-title":"Curr Pharm Des"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1667\/RR3196","article-title":"A sense of danger from radiation.","volume":"162","author":"WH McBride","year":"2004","journal-title":"Radiat Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1200\/JCO.2010.30.4212","article-title":"Harnessing innate immunity to suppress lymphoma.","volume":"28","author":"FK Stevenson","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1084\/jem.20052494","article-title":"Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy.","volume":"203","author":"EA Reits","year":"2006","journal-title":"J Exp Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1290\/0508054.1","article-title":"Gamma-radiation upregulates MHC class I\/II and ICAM-I molecules in multiple myeloma cell lines and primary tumors.","volume":"42","author":"M Chiriva-Internati","year":"2006","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.4049\/jimmunol.181.5.3099","article-title":"Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells.","volume":"181","author":"S Matsumura","year":"2008","journal-title":"J Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.4049\/jimmunol.180.5.3132","article-title":"Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity.","volume":"180","author":"AA Lugade","year":"2008","journal-title":"J Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1158\/0008-5472.CAN-04-0073","article-title":"External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing.","volume":"64","author":"M Chakraborty","year":"2004","journal-title":"Cancer Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ijrobp.2005.06.032","article-title":"Combining radiotherapy and immunotherapy: a revived partnership.","volume":"63","author":"S Demaria","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.onc.1210911","article-title":"Toll-like receptor 9 (TLR9) agonists in the treatment of cancer.","volume":"27","author":"AM Krieg","year":"2008","journal-title":"Oncogene"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity.","volume":"124","author":"S Akira","year":"2006","journal-title":"Cell"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/ni1479","article-title":"Ligand-induced conformational changes allosterically activate Toll-like receptor 9.","volume":"8","author":"E Latz","year":"2007","journal-title":"Nat Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses.","volume":"5","author":"A Iwasaki","year":"2004","journal-title":"Nat Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.jamcollsurg.2006.05.208","article-title":"Interleukin-18 and the toll-like receptor 9 ligand CpG stimulate murine splenic natural killer dendritic cells (NKDC) to proliferate and secrete IFN-gamma.","volume":"203","author":"U Chaudhry","year":"2006","journal-title":"Journal of the American College of Surgeons"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"10497","DOI":"10.1158\/0008-5472.CAN-06-1908","article-title":"Combined Stimulation with Interleukin-18 and CpG Induces Murine Natural Killer Dendritic Cells to Produce IFN-{gamma} and Inhibit Tumor Growth.","volume":"66","author":"UI Chaudhry","year":"2006","journal-title":"Cancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrd2059","article-title":"Therapeutic potential of Toll-like receptor 9 activation.","volume":"5","author":"AM Krieg","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1158\/1078-0432.CCR-08-2628","article-title":"Treatment of mammary carcinomas in HER-2 transgenic mice through combination of genetic vaccine and an agonist of Toll-like receptor 9.","volume":"15","author":"L Aurisicchio","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1182\/blood-2008-02-140673","article-title":"Toll-like receptors: lessons to learn from normal and malignant human B cells.","volume":"112","author":"D Chiron","year":"2008","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"12468","DOI":"10.1073\/pnas.0705226104","article-title":"TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts.","volume":"104","author":"V Damiano","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.4049\/jimmunol.164.3.1617","article-title":"Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo.","volume":"164","author":"G Hartmann","year":"2000","journal-title":"J Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"6925","DOI":"10.1073\/pnas.0501729102","article-title":"Immunomodulatory oligonucleotides containing a cytosine-phosphate-2&apos;-deoxy-7-deazaguanosine motif as potent Toll-like receptor 9 agonists.","volume":"102","author":"ER Kandimalla","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1093\/nar\/gkg343","article-title":"Divergent synthetic nucleotide motif recognition pattern: design and development of potent immunomodulatory oligodeoxyribonucleotide agents with distinct cytokine induction profiles.","volume":"31","author":"ER Kandimalla","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.vaccine.2004.11.028","article-title":"Oral administration of second-generation immunomodulatory oligonucleotides induces mucosal Th1 immune responses and adjuvant activity.","volume":"23","author":"D Wang","year":"2005","journal-title":"Vaccine"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1158\/1535-7163.MCT-06-0094","article-title":"Chemotherapy and chemosensitization of non-small cell lung cancer with a novel immunomodulatory oligonucleotide targeting Toll-like receptor 9.","volume":"5","author":"H Wang","year":"2006","journal-title":"Molecular Cancer Therapeutics"},{"key":"ref27","first-page":"901","article-title":"Immunopharmacological and antitumor effects of second-generation immunomodulatory oligonucleotides containing synthetic CpR motifs.","volume":"24","author":"D Wang","year":"2004","journal-title":"Int J Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2172-11-45","article-title":"Tumor vaccine composed of C-class CpG oligodeoxynucleotides and irradiated tumor cells induces long-term antitumor immunity.","volume":"11","author":"P Cerkovnik","year":"2010","journal-title":"BMC Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1349-7006.2009.01114.x","article-title":"Combination immunotherapy with radiation and CpG-based tumor vaccination for the eradication of radio- and immuno-resistant lung carcinoma cells.","volume":"100","author":"K Chamoto","year":"2009","journal-title":"Cancer Sci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1158\/1078-0432.361.11.1","article-title":"Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.","volume":"11","author":"KA Mason","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1158\/0008-5472.CAN-04-0926","article-title":"CpG oligodeoxynucleotide enhances tumor response to radiation.","volume":"64","author":"L Milas","year":"2004","journal-title":"Cancer Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4460","DOI":"10.1093\/nar\/gkf582","article-title":"\u2018Immunomers\u2019\u2013novel 3&apos;-3&apos;-linked CpG oligodeoxyribonucleotides as potent immunomodulatory agents.","volume":"30","author":"D Yu","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/(SICI)1097-0215(19991022)84:5<506::AID-IJC10>3.0.CO;2-6","article-title":"Humoral immune responses of cancer patients against \u201cCancer-Testis\u201d antigen NY-ESO-1: correlation with clinical events.","volume":"84","author":"E Jager","year":"1999","journal-title":"Int J Cancer"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"14303","DOI":"10.1073\/pnas.2335947100","article-title":"A dinucleotide motif in oligonucleotides shows potent immunomodulatory activity and overrides species-specific recognition observed with CpG motif.","volume":"100","author":"ER Kandimalla","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.4049\/jimmunol.174.5.2612","article-title":"Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-gamma via autocrine IL-12.","volume":"174","author":"VG Pillarisetty","year":"2005","journal-title":"J Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1158\/1078-0432.CCR-09-0265","article-title":"Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody.","volume":"15","author":"MZ Dewan","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death.","volume":"13","author":"M Obeid","year":"2007","journal-title":"Nat Med"},{"key":"ref38","article-title":"Synergizing radiation therapy and immunotherapy for curing incurable cancers. Opportunities and challenges.","volume":"1084","author":"JW Hodge","year":"2008","journal-title":"Oncology (Williston Park) 22: 1064\u20131070; discussion 1075, 1080\u20131061,"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e29357","DOI":"10.1371\/journal.pone.0029357","article-title":"TLR9 agonist protects mice from radiation-induced gastrointestinal syndrome.","volume":"7","author":"S Saha","year":"2012","journal-title":"PLoS One"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0038111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:51:10Z","timestamp":1687481470000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0038111"}},"subtitle":[],"editor":[{"given":"Keith L.","family":"Black","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,5,30]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0038111","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,30]]}}}